Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Halstenson

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Drug Intelligence & Clinical Pharmacy|June 1, 1984
Heparin interferes with tobramycin serum concentration determinations by EmitG R Matzke, K Piveral, C E Halstenson, et al.
Clinical Pharmacokinetics|March 1, 1992
Clinical pharmacokinetics of antibiotics in patients with impaired renal functionW L St Peter, K A Redic-Kill, C E Halstenson
Antimicrobial Agents and Chemotherapy|May 1, 1984
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysisR D Blevins, C E Halstenson, N G Salem, et al.
Journal of Clinical Pharmacology|December 1, 1994
A dose-ranging pharmacokinetics study of sodium diethyldithiocarbamate in normal healthy volunteersW M Awni, J V Hoff, B E Shapiro, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1987
Aminoglycoside redistribution phenomenon after hemodialysis: netilmicin and tobramycinC E Halstenson, R O Berkseth, H J Mann, et al.
Clinical Pharmacology and Therapeutics|November 1, 1990
Validity of creatinine clearance estimates in the assessment of renal functionD R Luke, C E Halstenson, J A Opsahl, et al.
Kidney International|January 1, 1996
Determination of residual renal function with iohexol clearance in hemodialysis patientsS K Swan, C E Halstenson, B L Kasiske, et al.
Journal of Clinical Microbiology|December 1, 1984
Analytical accuracy of determinations of aminoglycoside concentrations by enzyme multiplied immunoassay, fluorescence polarization immunoassay, and radioimmunoassay in the presence of heparinM E O'Connell, K L Heim, C E Halstenson, et al.
Journal of Analytical Toxicology|May 1, 1984
Analytical specificity of commercially available methods for serum phenytoin determinationD B Haughey, G R Matzke, C E Halstenson, et al.
Archives of Internal Medicine|November 1, 1988
Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiencyP A Abraham, J A Opsahl, C E Halstenson, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Drug Intelligence & Clinical Pharmacy|June 1, 1984
Heparin interferes with tobramycin serum concentration determinations by EmitG R Matzke, K Piveral, C E Halstenson, et al.
Clinical Pharmacokinetics|March 1, 1992
Clinical pharmacokinetics of antibiotics in patients with impaired renal functionW L St Peter, K A Redic-Kill, C E Halstenson
Antimicrobial Agents and Chemotherapy|May 1, 1984
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysisR D Blevins, C E Halstenson, N G Salem, et al.
Journal of Clinical Pharmacology|December 1, 1994
A dose-ranging pharmacokinetics study of sodium diethyldithiocarbamate in normal healthy volunteersW M Awni, J V Hoff, B E Shapiro, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1987
Aminoglycoside redistribution phenomenon after hemodialysis: netilmicin and tobramycinC E Halstenson, R O Berkseth, H J Mann, et al.
Clinical Pharmacology and Therapeutics|November 1, 1990
Validity of creatinine clearance estimates in the assessment of renal functionD R Luke, C E Halstenson, J A Opsahl, et al.
Kidney International|January 1, 1996
Determination of residual renal function with iohexol clearance in hemodialysis patientsS K Swan, C E Halstenson, B L Kasiske, et al.
Journal of Clinical Microbiology|December 1, 1984
Analytical accuracy of determinations of aminoglycoside concentrations by enzyme multiplied immunoassay, fluorescence polarization immunoassay, and radioimmunoassay in the presence of heparinM E O'Connell, K L Heim, C E Halstenson, et al.
Journal of Analytical Toxicology|May 1, 1984
Analytical specificity of commercially available methods for serum phenytoin determinationD B Haughey, G R Matzke, C E Halstenson, et al.
Archives of Internal Medicine|November 1, 1988
Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiencyP A Abraham, J A Opsahl, C E Halstenson, et al.
Pageof 9